MACKENZIE FINANCIAL CORP, a registered investment adviser, initiated a new position in Johnson & Johnson (NYSE:JNJ) during Q4 2025, according to its most recent 13F filing with the Securities and Exchange Commission.
The institutional investor purchased 4,448,059 shares of the Healthcare company, valued at approximately $918.5M as of the filing date.
Johnson & Johnson's stock currently trades at $245.94 with a market capitalization of $505.8B.
